Literature DB >> 16986059

Pathophysiology of lower urinary tract symptoms in the aging male population.

Herbert Lepor.   

Abstract

Nearly all men will develop histological benign prostatic hyperplasia by the age of 80, but the degree of prostatic enlargement resulting from the hyperplasia is highly variable. Historically, it has often been assumed that the pathophysiology of lower urinary tract symptoms (LUTS) in men is the result of bladder outlet obstruction associated with prostatic enlargement. The observation that prostatic enlargement, bladder outlet obstruction, and LUTS are all age-dependent has been interpreted to indicate that these phenomena were causally related, but there is insufficient evidence for this. Undoubtedly, some men's prostatic enlargement causes obstruction and symptoms. Based on the available data, however, this subset appears to be extremely small. Because of the many urological and nonurological conditions that cause LUTS and age-dependent changes in bladder and neurological function, it is unlikely that there exists a single dominant etiology for the aging male population. If this is the case, then the optimal management of LUTS will require different and possibly combination therapies.

Entities:  

Year:  2005        PMID: 16986059      PMCID: PMC1477625     

Source DB:  PubMed          Journal:  Rev Urol        ISSN: 1523-6161


  23 in total

1.  Radical retropubic prostatectomy reduces symptom scores and improves quality of life in men with moderate and severe lower urinary tract symptoms.

Authors:  E J Schwartz; H Lepor
Journal:  J Urol       Date:  1999-04       Impact factor: 7.450

Review 2.  Natural history of benign prostatic hyperplasia.

Authors:  S J Jacobsen; C J Girman; M M Lieber
Journal:  Urology       Date:  2001-12       Impact factor: 2.649

3.  Relationship of symptoms of prostatism to commonly used physiological and anatomical measures of the severity of benign prostatic hyperplasia.

Authors:  M J Barry; A T Cockett; H L Holtgrewe; J D McConnell; S A Sihelnik; H N Winfield
Journal:  J Urol       Date:  1993-08       Impact factor: 7.450

4.  Effect of terazosin on prostatism in men with normal and abnormal peak urinary flow rates.

Authors:  H Lepor; A Nieder; J Feser; C O'Connell; C Dixon
Journal:  Urology       Date:  1997-03       Impact factor: 2.649

5.  Neurally mediated hyperactive voiding in spontaneously hypertensive rats.

Authors:  J M Spitsbergen; D B Clemow; R McCarty; W D Steers; J B Tuttle
Journal:  Brain Res       Date:  1998-04-20       Impact factor: 3.252

6.  Autonomic receptors in human prostate adenomas.

Authors:  D I Gup; E Shapiro; M Baumann; H Lepor
Journal:  J Urol       Date:  1990-01       Impact factor: 7.450

7.  Determination of norepinephrine levels in the adult human prostate.

Authors:  H Lepor; E Shapiro; R R Bowsher; D P Henry
Journal:  J Urol       Date:  1990-11       Impact factor: 7.450

8.  Anti-desmin vs. anti-actin for quantifying the area density of prostate smooth muscle.

Authors:  E Shapiro; V Hartanto; H Lepor
Journal:  Prostate       Date:  1992       Impact factor: 4.104

9.  The impact of medical therapy on bother due to symptoms, quality of life and global outcome, and factors predicting response. Veterans Affairs Cooperative Studies Benign Prostatic Hyperplasia Study Group.

Authors:  H Lepor; W O Williford; M J Barry; C Haakenson; K Jones
Journal:  J Urol       Date:  1998-10       Impact factor: 7.450

10.  The development of human benign prostatic hyperplasia with age.

Authors:  S J Berry; D S Coffey; P C Walsh; L L Ewing
Journal:  J Urol       Date:  1984-09       Impact factor: 7.450

View more
  28 in total

1.  The role of gonadotropin-releasing hormone antagonists for the treatment of benign prostatic hyperplasia.

Authors:  Herbert Lepor
Journal:  Rev Urol       Date:  2006

2.  Correlation between prostate volume and single nucleotide polymorphisms implicated in the steroid pathway.

Authors:  Jean-Nicolas Cornu; Etienne Audet-Walsh; Sarah Drouin; Pierre Bigot; Antoine Valeri; Georges Fournier; Abdel-Rahmène Azzouzi; Morgan Roupret; Luc Cormier; Stephen Chanock; Chantal Guillemette; Olivier Cussenot; Eric Lévesque; Géraldine Cancel-Tassin
Journal:  World J Urol       Date:  2016-06-08       Impact factor: 4.226

Review 3.  The efficacy and safety of silodosin in treating BPH: a systematic review and meta-analysis.

Authors:  Yuanshan Cui; Huantao Zong; Yong Zhang
Journal:  Int Urol Nephrol       Date:  2012-08-24       Impact factor: 2.370

4.  Management of urinary incontinence.

Authors:  George A Demaagd; Timothy C Davenport
Journal:  P T       Date:  2012-06

Review 5.  Links between lower urinary tract symptoms, intermittent hypoxia and diabetes: Causes or cures?

Authors:  Lisa L Abler; Chad M Vezina
Journal:  Respir Physiol Neurobiol       Date:  2017-09-18       Impact factor: 1.931

6.  Impact of sex, androgens, and prostate size on C57BL/6J mouse urinary physiology: functional assessment.

Authors:  Hannah Ruetten; Kyle A Wegner; Helen L Zhang; Peiqing Wang; Jaskiran Sandhu; Simran Sandhu; Brett Mueller; Zunyi Wang; Jill Macoska; Richard E Peterson; Dale E Bjorling; William A Ricke; Paul C Marker; Chad M Vezina
Journal:  Am J Physiol Renal Physiol       Date:  2019-08-07

7.  Increased susceptibility of estrogen-induced bladder outlet obstruction in a novel mouse model.

Authors:  Neville Ngai-Chung Tam; Xiang Zhang; Hong Xiao; Dan Song; Linda Levin; Jarek Meller; Shuk-Mei Ho
Journal:  Lab Invest       Date:  2015-02-23       Impact factor: 5.662

Review 8.  Personalized medicine for the management of benign prostatic hyperplasia.

Authors:  Seth K Bechis; Alexander G Otsetov; Rongbin Ge; Aria F Olumi
Journal:  J Urol       Date:  2014-02-25       Impact factor: 7.450

9.  Amitriptyline aggravates the fibrosis process in a rat model of infravesical obstruction.

Authors:  Patrícia S de Almeida Prado; Maria Fernanda Soares; Flávio O Lima; Nestor Schor; Vicente P C Teixeira
Journal:  Int J Exp Pathol       Date:  2012-05-08       Impact factor: 1.925

10.  Super early detailed assessment of lower urinary tract symptoms after holmium laser enucleation of the prostate (HoLEP): a prospective study.

Authors:  Sascha A Ahyai; Irina Marik; Tim A Ludwig; Andreas Becker; Saman Asdjodi; Luis Kluth; Felix Chun; Margit Fisch; Marianne Schmid
Journal:  World J Urol       Date:  2020-02-21       Impact factor: 4.226

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.